NeuroPace, Inc.
NPCE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $80 | $65 | $46 | $45 |
| % Growth | 22.1% | 43.7% | 0.7% | – |
| Cost of Goods Sold | $21 | $17 | $13 | $12 |
| Gross Profit | $59 | $48 | $32 | $33 |
| % Margin | 73.9% | 73.6% | 71.4% | 74% |
| R&D Expenses | $24 | $21 | $22 | $18 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $57 | $55 | $51 | $39 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $81 | $75 | $73 | $57 |
| Operating Income | -$22 | -$27 | -$41 | -$24 |
| % Margin | -27.1% | -41.5% | -89.6% | -52.5% |
| Other Income/Exp. Net | -$5 | -$6 | -$6 | -$12 |
| Pre-Tax Income | -$27 | -$33 | -$47 | -$36 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$27 | -$33 | -$47 | -$36 |
| % Margin | -34% | -50.4% | -103.4% | -79.9% |
| EPS | -0.93 | -1.27 | -1.91 | -2.17 |
| % Growth | 26.8% | 33.5% | 12% | – |
| EPS Diluted | -0.93 | -1.27 | -1.91 | -2.17 |
| Weighted Avg Shares Out | 29 | 26 | 25 | 17 |
| Weighted Avg Shares Out Dil | 29 | 26 | 25 | 17 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3 | $3 | $2 | $0 |
| Interest Expense | $9 | $9 | $8 | $7 |
| Depreciation & Amortization | $2 | $2 | $3 | $0 |
| EBITDA | -$17 | -$23 | -$37 | -$28 |
| % Margin | -20.7% | -34.9% | -80.3% | -62.8% |